Evidence map›Paper›PMID 39462671›Full record

ArticleSheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi2024

[Functional study of amine oxidase copper-containing 1 (AOC1) in lipid metabolism].

Siting Xiang, Shenying Liu, Kuangzheng Li, Tongjin Zhao, Xu Wang

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Siting XiangInstitute of Metabolism and Integrative Biology, Fudan University, Shanghai 200438, P. R. China.
Shenying LiuInstitute of Metabolism and Integrative Biology, Fudan University, Shanghai 200438, P. R. China.
Kuangzheng LiInstitute of Metabolism and Integrative Biology, Fudan University, Shanghai 200438, P. R. China.
Tongjin ZhaoInstitute of Metabolism and Integrative Biology, Fudan University, Shanghai 200438, P. R. China.
Xu WangInstitute of Metabolism and Integrative Biology, Fudan University, Shanghai 200438, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amine oxidase copper-containing 1 (AOC1) is a key member of copper amine oxidase family, which is responsible for deamination oxidation of histamine and putrescine. In recent years, AOC1 has been reported to be associated with various cancers, with its expression levels significantly elevated in certain cancer cells, suggesting its potential role in cancer progression. However, its function in lipid metabolism still remains unclear. Through genetic analysis, we have discovered a potential relationship between AOC1 and lipid metabolism. To further investigate, we generated

Indexed as

Amine Oxidase (Copper-Containing)Diet, High-FatLipid MetabolismObesityAdipose Tissue, WhiteAnimalsDiabetes Mellitus, Type 2HumansLiverMiceMice, Inbred C57BLMice, KnockoutAmine Oxidase (Copper-Containing)Amine oxidase copper-containing 1Lipid metabolismObesity model

Identifiers

PMID39462671
PMCPMC11527758

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.